Moderately increased IL-6 levels seen in obese individuals may contribute to the development of obesity-associated complications, e.g., insulin resistance, via the inhibition of lipoprotein lipase activity in the adipose tissue [21,42]. This evidence concerns the gene LPL and obesity due to melanocortin 4 receptor deficiency.